BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17954482)

  • 1. Clinical trials in paediatric haematology-oncology: are future successes threatened by the EU directive on the conduct of clinical trials?
    Mitchell C
    Arch Dis Child; 2007 Nov; 92(11):1024-7. PubMed ID: 17954482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quality management within the competence network of paediatric oncology and haematology].
    Creutzig U; Zimmermann M; Hannemann J; Krämer I; Herold R; Henze G
    Klin Padiatr; 2003; 215(6):338-40. PubMed ID: 14677099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmful impact of EU clinical trials directive.
    Hemminki A; Kellokumpu-Lehtinen PL
    BMJ; 2006 Mar; 332(7540):501-2. PubMed ID: 16513690
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology].
    Creutzig U; Jürgens H; Herold R; Göbel U; Henze G
    Klin Padiatr; 2004; 216(6):379-83. PubMed ID: 15565554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality management for clinical trials within the German Competence Network Paediatric Oncology and Haematology.
    Creutzig U; Zimmermann M; Hannemann J; Krämer I; Pfistner B; Herold R; Henze G
    Onkologie; 2005 Jun; 28(6-7):333-6. PubMed ID: 15933421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experience of a single Australian paediatric oncology unit. 1000 patients 1964-1987.
    McCowage GB; Vowels MR; Brown R; O'Gorman-Hughes D; White L; Marshall G
    Med J Aust; 1993 Oct; 159(7):453-5, 458. PubMed ID: 8412916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The "quality house pediatric oncology" as an instrument for improving the performance of the trial centers].
    Creutzig U; Hannemann J; Krämer I; Zimmermann M; Herold R; Marx JF
    Klin Padiatr; 2005; 217(3):114-9. PubMed ID: 15858701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of staffing and infrastructures of paediatric oncology and haematology centres in Germany].
    Herold R; Reiche R; Creutzig U; Henze G
    Klin Padiatr; 2007; 219(6):380-90. PubMed ID: 18050051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating treatments for childhood cancer. A process for critical appraisal of the literature and a summary of the results.
    Barr RD; Furlong W; Feeny D; Horsman J; Rosenbaum P; Weitzman S
    Int J Technol Assess Health Care; 1995; 11(1):1-10. PubMed ID: 7706006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Foreward].
    Ehninger G; Overkamp F; Freund M;
    Onkologie; 2013; 36 Suppl 2():1. PubMed ID: 23549029
    [No Abstract]   [Full Text] [Related]  

  • 11. Harmful impact of EU clinical trials directive: ...while paediatric oncology is being scuppered.
    Mitchell CD
    BMJ; 2006 Mar; 332(7542):666. PubMed ID: 16543345
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adult leukemia: current status of the clinical studies in Japan Adult Leukemia Study Group].
    Miyazaki Y
    Rinsho Ketsueki; 2006 Jul; 47(7):579-86. PubMed ID: 16910566
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.
    Morgan JE; Hassan H; Cockle JV; Lethaby C; James B; Phillips RS
    Support Care Cancer; 2017 Jan; 25(1):221-228. PubMed ID: 27614870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The past and future of cancer in the young.
    Bleyer WA
    Pediatr Dent; 1995; 17(4):285-90. PubMed ID: 7567632
    [No Abstract]   [Full Text] [Related]  

  • 15. Diversified harmony: supranational and domestic regulation of pediatric clinical trials in the European Union.
    Pinxten W; Dierickx K; Nys H
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S183-98. PubMed ID: 21658637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Survey on Standards of Care in paediatric oncology centres.
    Kowalczyk JR; Samardakiewicz M; Pritchard-Jones K; Ladenstein R; Essiaf S; Fitzgerald E; Petrarulo G; Vassal G
    Eur J Cancer; 2016 Jul; 61():11-9. PubMed ID: 27131152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TARGETing high-risk childhood cancers.
    Scudellari M
    Cancer Discov; 2012 Jul; 2(7):576. PubMed ID: 22787076
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy with CAR-T cells in paediatric haematology-oncology].
    Mirones I; Moreno L; Patiño-García A; Lizeaga G; Moraleda JM; Toribio ML; Pérez-Martínez A; ;
    An Pediatr (Engl Ed); 2020 Jul; 93(1):59.e1-59.e10. PubMed ID: 32107177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.
    Welzing L; Harnischmacher U; Weyersberg A; Roth B
    Eur J Pediatr; 2007 Nov; 166(11):1169-76. PubMed ID: 17333274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality and safety in pediatric hematology/oncology.
    Mueller BU
    Pediatr Blood Cancer; 2014 Jun; 61(6):966-9. PubMed ID: 24481936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.